All available patient information was included.Additional patient details are not available.An evaluation is in process.A final report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 08d06-39 that has a similar product distributed in the us, list number 08d06-41.
|
A review of tickets determined that there is normal complaint activity for lot 04643be01 and no trends were identified.Return testing was not completed as returns were not available.Sensitivity testing was performed with a retained kit of lot 04643be00 (contains the same material as lot 04643be01) and a sensitivity panel.Results of this setup did not implicate that the performance of the lot is negatively impacted.No false non-reactive results were obtained.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect syphilis tp reagent, lot 04643be01.Correction to suspect medical device, 4.Catalog# from 08d06-36 to 08d06-77, lot # from 04643be00 to 04643be01, and udi from (b)(4) to blank.
|